Sugat Patel, MD
Retina Specialist · Dublin, OHNPI 1831288448
Payments from drug & device makers
What this record shows
This record is dominated by ownership interests: $21,845 of the $33,300 with a category attached, or 65.6%. US Retina LLC accounts for 65.6% of it on its own, with 27 other manufacturers making up the rest. Reporting peaked in 2022 at $10,889 and has fallen 71.3% since, to $3,125 in 2025.
Across 276 payments — averaging $120.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- US Retina LLC$22K
- Genentech USA, Inc.$2K
- Regeneron Healthcare Solutions, Inc.$2K
- Onmark, Inc.$2K
- Alimera Sciences, Inc.$1K
- AbbVie$1K
- plus $4K from 22 others
Across 319 payments — averaging $3709.72 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$537K
- Bayer$309K
- Regeneron$251K
- Novartis$67K
- AbbVie$20K
What the payments were for
- Travel & lodging$8863%
- Food & beverage$10,53432%
- Education$170%
- Gifts$170%
- Ownership interest$21,84566%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| US Retina LLC | 6 | $21,845 |
| Genentech USA, Inc. | 50 | $1,730 |
| Regeneron Healthcare Solutions, Inc. | 45 | $1,548 |
| Onmark, Inc. | 10 | $1,535 |
| Alimera Sciences, Inc. | 34 | $1,322 |
| AbbVie(2 entities) | 27 | $1,059 |
| Bausch & Lomb Americas Inc. | 15 | $755 |
| Apellis Pharmaceuticals, Inc. | 16 | $750 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 11 | $473 |
| Novartis | 6 | $326 |
| Dutch Ophthalmic, USA | 4 | $250 |
| Eyepoint US, Inc. | 6 | $197 |
| Astellas Pharma US Inc | 6 | $182 |
| Eyevance Pharmaceuticals LLC | 2 | $169 |
| Genentech, Inc. | 2 | $151 |
| Amgen(2 entities) | 5 | $147 |
| Regeneron | 1 | $110 |
| Harrow Eye, LLC | 3 | $105 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $100 |
| Coherus Oncology, Inc. | 5 | $92 |
| ANI Pharmaceuticals, Inc. | 3 | $88 |
| Mallinckrodt Hospital Products Inc. | 3 | $76 |
| Sandoz | 3 | $65 |
| Biogen | 4 | $65 |
| Carl Zeiss Meditec, Inc. | 2 | $57 |
| Alcon | 2 | $41 |
| Omeros Corporation | 2 | $35 |
| Halozyme Inc | 2 | $27 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Iluvien$490
- VABYSMO$429
- STELLARIS$387
- Syfovre$338
- EYLEA$314
- Lucentis$255
- SUSVIMO$255
- XIPERE$244
- EYLEA HD$243
- OZURDEX$243
- EVA Ophthalmic Surgical System$177
- Tobradex ST$165
- STELLARIS PC$150
- VYZULTA$117
- YUTIQ$111
- EYP-1901$108
- Catalys Laser System$100
How this compares
$33,300 in reported general payments places this provider in the 80th percentile of 69 retina specialist providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 236 | $6,582 |
| Atropine Sulfate | 89 | $2,461 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 176 | $1,770 |
| Timolol Maleate | 182 | $1,383 |
| Ketorolac Tromethamine | 70 | $1,045 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 28 | $460 |
| Brimonidine Tartrate | 68 | $441 |
| Dorzolamide Hcl | 17 | $357 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Dublin
- Louis ChorichDublin$40K
- Dino KlisovicDublin$21K
- Dominic BuzzaccoDublin$12K
- Vishal ParikhDublin$11K
- Johnstone KimDublin$10K
- Joseph ConeyBeachwood$980K
- Sumit SharmaCleveland$428K
- Aleksandra RachitskayaCleveland$303K
- David MillerBeachwood$299K
- Katherine TalcottCleveland$272K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.